Cormorant Asset Management, LP - PHASEBIO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$3,405,000
-71.4%
816,448
-9.9%
0.21%
-69.7%
Q2 2019$11,890,000
+48.9%
906,229
+7.9%
0.68%
+26.5%
Q1 2019$7,985,000
+135.3%
839,642
-23.5%
0.54%
+96.4%
Q4 2018$3,393,0001,097,9260.28%
Other shareholders
PHASEBIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 1,607,044$5,400,0000.70%
NEA Management Company, LLC 6,643,704$22,323,0000.59%
DAFNA Capital Management LLC 320,542$1,077,0000.32%
Platform Technology Partners 141,025$474,0000.23%
Parkman Healthcare Partners LLC 110,547$371,0000.10%
Rock Springs Capital Management LP 1,314,374$4,416,0000.09%
GSA CAPITAL PARTNERS LLP 140,341$472,0000.08%
SABBY MANAGEMENT, LLC 65,000$218,0000.04%
Virtu Financial LLC 28,821$97,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 127,600$429,0000.01%
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders